Home > Stem Cell Research > Our Published Papers > Article Content

Stem cell transplantation in 20 patients with multiple system atrophy

Author Julia Views Posted at 2014/02/17

Journal Of Clinical Rehabilitation Tissue Engineering Research November 5,2009 Vol.13,No.45

Wu Like, Wang Xiaojuan,Xu Baolei, Liu Shuangshuang,Chu Saichun,Cheng Bo
Beijing Wu Stem Cells Medical Center, Beijing China 100070

OBJECTIVE: To observe the outcomes of umbilical cord blood mesenchymal stem cell transplantation for treating neural function of multiple system atrophy (MSA) patients.
METHODS: A total of 20 MSA patients were selected at the Beijing Wu Stem Cells Medical Center from January to October 2008. All patients received treatment of vessel distention, anti-free radical, trophic nerve and cell membrane stabilization, as well as umbilical cord blood mesenchymal stem cell transplantation intrathecal injection. Patients at left-lateral position, and body bent at hips, knees and necks. Acupuncture was conducted at the space of lumbar vertebra 3 and 4. Following local anesthesia, No. 9 needle was directly pricked into the subarachnoid cavity. 2 mg dexamethasone was slowly infused, and 5 mL (5��106 stem cells) umbilical cord blood mesenchymal stem cell injection was obtained and slowly infused into the subarachnoid cavity within 10 minutes, once per week, four times as a course, totally one course. We adopted Unified Multiple System Atrophy Rating Scale (UMSARS) to evaluate those MSA patients. The higher score represented a severe pathogenetic condition. RESULTS: Compared with pretransplantation, the UMSARS score was significantly decreased in 20 patients 4 weeks following transplantation ( < 0.01). After the treatment, patient's clinical symptoms such as slow movement, balance disturbance, orthostatic hypotension, urinary and bowel disorders had full obvious improvement. Graft versus host disease was not found. CONCLUSION: It is indicated that mesenchymal stem cell transplantation is effective, can partly improve MSA patients' clinical symptoms, and improve patients'life quality.

Read more: en/upfiles/pdf/Umbilical_cord_blood_mesenchymal_stem_cell_transplantation_in_20_patients_with_multiple_system_atrophy.pdf


Related Information:

    Tel: +86-10-83614168 Fax: +86-10-83614167 Email:  info@wumedicalcenter.com
    Add:198 Fengbao Road, Beijing, China Zip:100160  Contact Us 
    Copyright@2013 Runde Healthcare Consulting Limited.